138 related articles for article (PubMed ID: 27055748)
1. Cytotoxic Tumor-Targeting Peptides From In Vivo Phage Display.
Northup JR; Deutscher SL
Comb Chem High Throughput Screen; 2016; 19(5):370-7. PubMed ID: 27055748
[TBL] [Abstract][Full Text] [Related]
2. Streamlined in vivo selection and screening of human prostate carcinoma avid phage particles for development of peptide based in vivo tumor imaging agents.
Newton-Northup JR; Figueroa SD; Deutscher SL
Comb Chem High Throughput Screen; 2011 Jan; 14(1):9-21. PubMed ID: 20958260
[TBL] [Abstract][Full Text] [Related]
3. Discovery of peptide drug carrier candidates for targeted multi-drug delivery into prostate cancer cells.
Bashari O; Redko B; Cohen A; Luboshits G; Gellerman G; Firer MA
Cancer Lett; 2017 Nov; 408():164-173. PubMed ID: 28888997
[TBL] [Abstract][Full Text] [Related]
4. Bifunctional phage-based pretargeted imaging of human prostate carcinoma.
Newton-Northup JR; Figueroa SD; Quinn TP; Deutscher SL
Nucl Med Biol; 2009 Oct; 36(7):789-800. PubMed ID: 19720291
[TBL] [Abstract][Full Text] [Related]
5. Metastatic prostate cancer cell-specific phage-like particles as a targeted gene-delivery system.
Fagbohun OA; Kazmierczak RA; Petrenko VA; Eisenstark A
J Nanobiotechnology; 2013 Sep; 11():31. PubMed ID: 24059645
[TBL] [Abstract][Full Text] [Related]
6. In vivo selection of phage for the optical imaging of PC-3 human prostate carcinoma in mice.
Newton JR; Kelly KA; Mahmood U; Weissleder R; Deutscher SL
Neoplasia; 2006 Sep; 8(9):772-80. PubMed ID: 16984734
[TBL] [Abstract][Full Text] [Related]
7. Tumor-Targeting Peptides Search Strategy for the Delivery of Therapeutic and Diagnostic Molecules to Tumor Cells.
Dmitrieva MD; Voitova AA; Dymova MA; Richter VA; Kuligina EV
Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33396774
[TBL] [Abstract][Full Text] [Related]
8. Landscape phage fusion protein-mediated targeting of nanomedicines enhances their prostate tumor cell association and cytotoxic efficiency.
Jayanna PK; Bedi D; Gillespie JW; DeInnocentes P; Wang T; Torchilin VP; Bird RC; Petrenko VA
Nanomedicine; 2010 Aug; 6(4):538-46. PubMed ID: 20138246
[TBL] [Abstract][Full Text] [Related]
9. Phage display selection of peptides that affect prostate carcinoma cells attachment and invasion.
Romanov VI; Durand DB; Petrenko VA
Prostate; 2001 Jun; 47(4):239-51. PubMed ID: 11398171
[TBL] [Abstract][Full Text] [Related]
10. Peptide-conjugated nanoparticles for targeted imaging and therapy of prostate cancer.
Yeh CY; Hsiao JK; Wang YP; Lan CH; Wu HC
Biomaterials; 2016 Aug; 99():1-15. PubMed ID: 27209258
[TBL] [Abstract][Full Text] [Related]
11. Screening and Identification of Peptides Specifically Targeted to Gastric Cancer Cells from a Phage Display Peptide Library.
Sahin D; Taflan SO; Yartas G; Ashktorab H; Smoot DT
Asian Pac J Cancer Prev; 2018 Apr; 19(4):927-932. PubMed ID: 29693344
[TBL] [Abstract][Full Text] [Related]
12. Screening a phage display library for a novel FGF8b-binding peptide with anti-tumor effect on prostate cancer.
Wang W; Chen X; Li T; Li Y; Wang R; He D; Luo W; Li X; Wu X
Exp Cell Res; 2013 May; 319(8):1156-64. PubMed ID: 23466786
[TBL] [Abstract][Full Text] [Related]
13. In vitro high throughput phage display selection of ovarian cancer avid phage clones for near-infrared optical imaging.
Soendergaard M; Newton-Northup JR; Deutscher SL
Comb Chem High Throughput Screen; 2014; 17(10):859-67. PubMed ID: 25360673
[TBL] [Abstract][Full Text] [Related]
14. Screening of a specific peptide binding to esophageal squamous carcinoma cells from phage displayed peptide library.
Ma C; Li C; Jiang D; Gao X; Han J; Xu N; Wu Q; Nie G; Chen W; Lin F; Hou Y
Mol Cell Probes; 2015 Jun; 29(3):182-9. PubMed ID: 25886968
[TBL] [Abstract][Full Text] [Related]
15. Selection of internalizing ligand-display phage using rolling circle amplification for phage recovery.
Burg M; Ravey EP; Gonzales M; Amburn E; Faix PH; Baird A; Larocca D
DNA Cell Biol; 2004 Jul; 23(7):457-62. PubMed ID: 15294095
[TBL] [Abstract][Full Text] [Related]
16. Characterization of In Vivo Selected Bacteriophage for the Development of Novel Tumor-Targeting Agents with Specific Pharmacokinetics and Imaging Applications.
Newton-Northup J; Deutscher SL
Methods Mol Biol; 2017; 1572():445-465. PubMed ID: 28299705
[TBL] [Abstract][Full Text] [Related]
17. Nitroxide tempo, a small molecule, induces apoptosis in prostate carcinoma cells and suppresses tumor growth in athymic mice.
Suy S; Mitchell JB; Samuni A; Mueller S; Kasid U
Cancer; 2005 Mar; 103(6):1302-13. PubMed ID: 15685617
[TBL] [Abstract][Full Text] [Related]
18. Phage peptide display.
Newton J; Deutscher SL
Handb Exp Pharmacol; 2008; (185 Pt 2):145-63. PubMed ID: 18626602
[TBL] [Abstract][Full Text] [Related]
19. Dryopteris crassirhizoma has anti-cancer effects through both extrinsic and intrinsic apoptotic pathways and G0/G1 phase arrest in human prostate cancer cells.
Chang SH; Bae JH; Hong DP; Choi KD; Kim SC; Her E; Kim SH; Kang CD
J Ethnopharmacol; 2010 Jul; 130(2):248-54. PubMed ID: 20438825
[TBL] [Abstract][Full Text] [Related]
20. [Screening of targeting peptides for highly metastatic human ovarian cancer cells and their effect on the biological behavior of ovarian cancer cells].
Zhou C; Kang J; Wang X; Nie M; Jiang W
Zhonghua Zhong Liu Za Zhi; 2014 Aug; 36(8):565-70. PubMed ID: 25430020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
